Brief: Aptevo Therapeutics Quarterly Diluted EPS $5.58
11/08/2022 15:23
Aug 11 (Reuters) - Aptevo Therapeutics Inc APVO.O :
* APTEVO THERAPEUTICS INC- CASH, CASH EQUIVALENTS AND
RESTRICTED
CASH OF $30 MILLION AS OF JUNE 30, 2022
* APTEVO THERAPEUTICS INC- QTRLY DILUTED EPS $5.58
Further company coverage: APVO.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Aptevo Therapeutics
See all newsBrief: Aptevo Therapeutics - Enters Amendment No. 6 To Rights Agreement On October 23, 2026 - SEC Filing
U.S. STOCKS ON THE MOVE-Principal Financial Group, NetApp
U.S. STOCKS ON THE MOVE-Genesco, Fervo Energy, Tyson Foods
Aptevo Therapeutics reports early data for blood cancer therapy; shares fall
Aptevo Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary